Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Teva
AstraZeneca
Harvard Business School
Merck
Baxter
Chinese Patent Office
Dow
Accenture
Farmers Insurance
McKinsey

Generated: February 24, 2018

DrugPatentWatch Database Preview

Details for Patent: 6,235,712

« Back to Dashboard

Summary for Patent: 6,235,712
Title: Non-aqueous polar aprotic peptide formulations
Abstract:This invention relates to stable non-aqueous polar aprotic formulations of peptide compounds. These stable formulations comprise peptide in non-aqueous polar aprotic solvent. They may be stored at elevated temperatures for long periods of time and are especially useful in implantable delivery devices for long term delivery of drug.
Inventor(s): Stevenson; Cynthia L. (Mountain View, CA), Prestrelski; Steven J. (Mountain View, CA)
Assignee: ALZA Corporation (Mountain View, CA)
Application Number:09/514,951
Patent Claim Types:
see list of patent claims
Use; Formulation; Process; Dosage form; Delivery; Device;

Drugs Protected by US Patent 6,235,712

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

International Patents Family Members for US Patent 6,235,712

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
European Patent Office 1208846 ➤ Try a Free Trial
Spain 2181010 ➤ Try a Free Trial
Spain 2215967 ➤ Try a Free Trial
Hungary 9904270 ➤ Try a Free Trial
Norway 986207 ➤ Try a Free Trial
Norway 322514 ➤ Try a Free Trial
Malaysia 128850 ➤ Try a Free Trial
South Korea 20000022393 ➤ Try a Free Trial
Japan 2009073852 ➤ Try a Free Trial
Japan 2000515131 ➤ Try a Free Trial
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Moodys
UBS
Harvard Business School
Merck
US Department of Justice
Julphar
Express Scripts
Fuji
Cerilliant

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot